U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C6H4N2O6
Molecular Weight 200.1058
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of 3,5-DINITROCATECHOL

SMILES

OC1=CC(=CC(=C1O)[N+]([O-])=O)[N+]([O-])=O

InChI

InChIKey=VDCDWNDTNSWDFJ-UHFFFAOYSA-N
InChI=1S/C6H4N2O6/c9-5-2-3(7(11)12)1-4(6(5)10)8(13)14/h1-2,9-10H

HIDE SMILES / InChI
3,5-Dinitrocatechol (OR-486) is a selective inhibitor of catechol O-methyl transferase (COMT). COMT is an enzyme that plays a major role in catechol neurotransmitter deactivation. Inhibition of COMT can increase neurotransmitter levels, which provides a means of treatment for Parkinson's disease, schizophrenia, and depression.

CNS Activity

Curator's Comment: Known to be CNS penetrant in rat. Human data not available.

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
Target ID: P21964
Gene ID: 1312.0
Gene Symbol: COMT
Target Organism: Homo sapiens (Human)
12.0 nM [IC50]
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
PubMed

PubMed

TitleDatePubMed
Effects of tolcapone upon soluble and membrane-bound brain and liver catechol-O-methyltransferase.
1999 Mar 6
Role of adenosine in drug-induced catatonia in mice.
2002 Aug
Characterization of catechol glucuronidation in rat liver.
2002 Feb
Cytochromes 1A1/1B1- and catechol-O-methyltransferase-derived metabolites mediate estradiol-induced antimitogenesis in human cardiac fibroblast.
2005 Jan
Quantitative structure-activity relationships in prooxidant cytotoxicity of polyphenols: role of potential of phenoxyl radical/phenol redox couple.
2005 Sep 15
Patents

Sample Use Guides

in rat: orally administered OR-486 (3,5-DINITROCATECHOL) were more effective in reducing the formation of 3-O-methyldopa from levodopa than was the levodopa-carbidopa treatment alone. These results indicate that OR-486 is effective and long-lasting inhibitors of COMT activity.
Route of Administration: Oral
In Vitro Use Guide
Two novel COMT inhibitors, OR-462 and OR-486 (3,5-DINITROCATECHOL), were highly effective (IC50 = 18 and 12 nM, respectively) and selective in inhibiting COMT activity in vitro. Tyrosine hydroxylase was not inhibited until micromolar concentrations of these compounds were used: the IC50 values for OR-462 and OR-486 were 10 and 14 microM, respectively.
Name Type Language
3,5-DINITROCATECHOL
Systematic Name English
3,5-DINITROPYROCATECHOL
Systematic Name English
OR-486
Code English
1,2-BENZENEDIOL, 3,5-DINITRO-
Systematic Name English
ENTACAPONE IMPURITY E [EP IMPURITY]
Common Name English
3,5-DINITROBENZENE-1,2-DIOL
Systematic Name English
3,5-DINITRO-1,2-BENZENEDIOL
Systematic Name English
OR 486
Code English
1,2-DIHYDROXY-3,5-DINITROBENZENE
Systematic Name English
Code System Code Type Description
EPA CompTox
DTXSID00227391
Created by admin on Sat Dec 16 04:48:46 GMT 2023 , Edited by admin on Sat Dec 16 04:48:46 GMT 2023
PRIMARY
FDA UNII
VK0VA22GY2
Created by admin on Sat Dec 16 04:48:46 GMT 2023 , Edited by admin on Sat Dec 16 04:48:46 GMT 2023
PRIMARY
CAS
7659-29-2
Created by admin on Sat Dec 16 04:48:46 GMT 2023 , Edited by admin on Sat Dec 16 04:48:46 GMT 2023
PRIMARY
PUBCHEM
3870203
Created by admin on Sat Dec 16 04:48:46 GMT 2023 , Edited by admin on Sat Dec 16 04:48:46 GMT 2023
PRIMARY
DRUG BANK
DB02105
Created by admin on Sat Dec 16 04:48:46 GMT 2023 , Edited by admin on Sat Dec 16 04:48:46 GMT 2023
PRIMARY